Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1978 1
1979 3
1980 2
1981 6
1982 7
1983 8
1984 4
1985 4
1986 2
1987 6
1988 8
1989 11
1990 14
1991 9
1992 7
1993 13
1994 10
1995 7
1996 4
1997 5
1998 4
1999 11
2000 5
2001 8
2002 8
2003 15
2004 8
2005 7
2006 10
2007 21
2008 16
2009 17
2010 24
2011 22
2012 27
2013 26
2014 24
2015 23
2016 17
2017 17
2018 26
2019 29
2020 30
2021 40
2022 32
2023 27
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean t noji (807 results)?
Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes.
Fasolino M, Schwartz GW, Patil AR, Mongia A, Golson ML, Wang YJ, Morgan A, Liu C, Schug J, Liu J, Wu M, Traum D, Kondo A, May CL, Goldman N, Wang W, Feldman M, Moore JH, Japp AS, Betts MR; HPAP Consortium; Faryabi RB, Naji A, Kaestner KH, Vahedi G. Fasolino M, et al. Nat Metab. 2022 Feb;4(2):284-299. doi: 10.1038/s42255-022-00531-x. Epub 2022 Feb 28. Nat Metab. 2022. PMID: 35228745 Free PMC article.
Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity.
Muralidharan K, Agarwal D, Naji A, Bhoj VG. Muralidharan K, et al. J Immunol. 2022 Nov 15;209(10):1811-1816. doi: 10.4049/jimmunol.2200542. J Immunol. 2022. PMID: 36344114 Free PMC article. Review.
In this article, we review recent developments in the fields of T cell-based therapies and T cell engineering using chimeric Ag receptors and their potential for effective and targeted immune modulation of T and B cell activity in an effort to eliminate pre-e …
In this article, we review recent developments in the fields of T cell-based therapies and T cell engineering using chimeric A …
Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies.
Zhang Z, Markmann C, Yu M, Agarwal D, Rostami S, Wang W, Liu C, Zhao H, Ochoa T, Parvathaneni K, Xu X, Li E, Gonzalez V, Khadka R, Hoffmann J, Knox JJ, Scholler J, Marcellus B, Allman D, Fraietta JA, Samelson-Jones B, Milone MC, Monos D, Garfall AL, Naji A, Bhoj VG. Zhang Z, et al. Cell Rep Med. 2023 Dec 19;4(12):101336. doi: 10.1016/j.xcrm.2023.101336. Cell Rep Med. 2023. PMID: 38118406 Free PMC article.
We find that treatment of allo-sensitized hosts with CAR T cells targeting Bmems and LLPCs eliminates donor-specific allo-antibodies (DSAs) and mitigates hyperacute rejection of subsequent islet allografts. ...These findings provide logical rationale for clinical evaluatio …
We find that treatment of allo-sensitized hosts with CAR T cells targeting Bmems and LLPCs eliminates donor-specific allo-antibodies …
Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque.
Ellis GI, Coker KE, Winn DW, Deng MZ, Shukla D, Bhoj V, Milone MC, Wang W, Liu C, Naji A, Duran-Struuck R, Riley JL. Ellis GI, et al. Cell Rep Med. 2022 May 17;3(5):100614. doi: 10.1016/j.xcrm.2022.100614. Epub 2022 May 11. Cell Rep Med. 2022. PMID: 35551746 Free PMC article.
Adoptive transfer of chimeric antigen receptor regulatory T cells (CAR Tregs) is a promising way to prevent allograft loss without the morbidity associated with current therapies. ...
Adoptive transfer of chimeric antigen receptor regulatory T cells (CAR Tregs) is a promising way to prevent allograft loss without th …
L’obésité chez l’adulte : ligne directrice de pratique clinique.
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, Adamo K, Alberga A, Bell R, Boulé N, Boyling E, Brown J, Calam B, Clarke C, Crowshoe L, Divalentino D, Forhan M, Freedhoff Y, Gagner M, Glazer S, Grand C, Green M, Hahn M, Hawa R, Henderson R, Hong D, Hung P, Janssen I, Jacklin K, Johnson-Stoklossa C, Kemp A, Kirk S, Kuk J, Langlois MF, Lear S, McInnes A, Macklin D, Naji L, Manjoo P, Morin MP, Nerenberg K, Patton I, Pedersen S, Pereira L, Piccinini-Vallis H, Poddar M, Poirier P, Prud'homme D, Salas XR, Rueda-Clausen C, Russell-Mayhew S, Shiau J, Sherifali D, Sievenpiper J, Sockalingam S, Taylor V, Toth E, Twells L, Tytus R, Walji S, Walker L, Wicklum S. Wharton S, et al. CMAJ. 2020 Dec 7;192(49):E1757-E1775. doi: 10.1503/cmaj.191707-f. CMAJ. 2020. PMID: 33288515 Free PMC article. French. No abstract available.
The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses.
Noorchashm H, Greeley SA, Naji A. Noorchashm H, et al. Immunol Res. 2003;27(2-3):443-50. doi: 10.1385/IR:27:2-3:443. Immunol Res. 2003. PMID: 12857987 Review.
The present review highlights the two areas of research pursuit in our laboratory: (1). the regulation of the autoimmune T cell response to pancreatic islet beta cells using the nonobese diabetic (NOD) mouse model of type 1 diabetes and (2). the regulation the T cel …
The present review highlights the two areas of research pursuit in our laboratory: (1). the regulation of the autoimmune T cell respo …
Thin slab quantitative susceptibility mapping.
Naji N, Wilman A. Naji N, et al. Magn Reson Med. 2023 Dec;90(6):2290-2305. doi: 10.1002/mrm.29800. Epub 2023 Aug 1. Magn Reson Med. 2023. PMID: 37526029
593 results